84 related articles for article (PubMed ID: 8830675)
1. Identification of nonconserved amino acids in the AT1 receptor which comprise a general binding site for biphenylimidazole antagonists.
Nirula V; Zheng W; Krishnamurthi K; Sandberg K
FEBS Lett; 1996 Oct; 394(3):361-4. PubMed ID: 8830675
[TBL] [Abstract][Full Text] [Related]
2. Interaction of biphenylimidazole and imidazoleacrylic acid nonpeptide antagonists with valine 108 in TM III of the AT1 angiotensin receptor.
Nirula V; Zheng W; Sothinathan R; Sandberg K
Br J Pharmacol; 1996 Dec; 119(8):1505-7. PubMed ID: 8982494
[TBL] [Abstract][Full Text] [Related]
3. Differential structural requirements for specific binding of nonpeptide and peptide antagonists to the AT1 angiotensin receptor. Identification of amino acid residues that determine binding of the antihypertensive drug losartan.
Ji H; Leung M; Zhang Y; Catt KJ; Sandberg K
J Biol Chem; 1994 Jun; 269(24):16533-6. PubMed ID: 8206967
[TBL] [Abstract][Full Text] [Related]
4. Genetic transfer of a nonpeptide antagonist binding site to a previously unresponsive angiotensin receptor.
Ji H; Zheng W; Zhang Y; Catt KJ; Sandberg K
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9240-4. PubMed ID: 7568109
[TBL] [Abstract][Full Text] [Related]
5. Non-peptide angiotensin agonist. Functional and molecular interaction with the AT1 receptor.
Perlman S; Schambye HT; Rivero RA; Greenlee WJ; Hjorth SA; Schwartz TW
J Biol Chem; 1995 Jan; 270(4):1493-6. PubMed ID: 7829475
[TBL] [Abstract][Full Text] [Related]
6. Interaction between the nonpeptide angiotensin antagonist SKF-108,566 and histidine 256 (HisVI:16) of the angiotensin type 1 receptor.
Schambye HT; Hjorth SA; Weinstock J; Schwartz TW
Mol Pharmacol; 1995 Mar; 47(3):425-31. PubMed ID: 7700239
[TBL] [Abstract][Full Text] [Related]
7. Shared determinants of receptor binding for subtype selective, and dual endothelin-angiotensin antagonists on the AT1 angiotensin II receptor.
Dascal D; Nirula V; Lawus K; Yoo SE; Walsh TF; Sandberg K
FEBS Lett; 1998 Feb; 423(1):15-8. PubMed ID: 9506833
[TBL] [Abstract][Full Text] [Related]
8. Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants.
Monnot C; Bihoreau C; Conchon S; Curnow KM; Corvol P; Clauser E
J Biol Chem; 1996 Jan; 271(3):1507-13. PubMed ID: 8576145
[TBL] [Abstract][Full Text] [Related]
9. Interaction of a non-peptide agonist with angiotensin II AT1 receptor mutants.
Costa-Neto CM; Miyakawa AA; Pesquero JB; Oliveira L; Hjorth SA; Schwartz TW; Paiva AC
Can J Physiol Pharmacol; 2002 May; 80(5):413-7. PubMed ID: 12056547
[TBL] [Abstract][Full Text] [Related]
10. Tetrazole and carboxylate groups of angiotensin receptor antagonists bind to the same subsite by different mechanisms.
Noda K; Saad Y; Kinoshita A; Boyle TP; Graham RM; Husain A; Karnik SS
J Biol Chem; 1995 Feb; 270(5):2284-9. PubMed ID: 7530721
[TBL] [Abstract][Full Text] [Related]
11. Balanced AT1/AT2 receptor antagonists. 4. XR510 and related 5-(3-amidopropanoyl)imidazoles possessing equal affinity for the AT1 and AT2 receptors.
Quan ML; Chiu AT; Ellis CD; Wong PC; Wexler RR; Timmermans PB
J Med Chem; 1995 Jul; 38(15):2938-45. PubMed ID: 7636854
[TBL] [Abstract][Full Text] [Related]
12. Identification of atypical (non-AT1, non-AT2) angiotensin binding sites with high affinity for angiotensin I on IEC-18 rat intestinal epithelial cells.
Smith RD
FEBS Lett; 1995 Oct; 373(3):199-202. PubMed ID: 7589465
[TBL] [Abstract][Full Text] [Related]
13. Amino acids of the third transmembrane domain of the AT1A angiotensin II receptor are involved in the differential recognition of peptide and nonpeptide ligands.
Groblewski T; Maigret B; Nouet S; Larguier R; Lombard C; Bonnafous JC; Marie J
Biochem Biophys Res Commun; 1995 Apr; 209(1):153-60. PubMed ID: 7726829
[TBL] [Abstract][Full Text] [Related]
14. Dual agonistic and antagonistic property of nonpeptide angiotensin AT1 ligands: susceptibility to receptor mutations.
Perlman S; Costa-Neto CM; Miyakawa AA; Schambye HT; Hjorth SA; Paiva AC; Rivero RA; Greenlee WJ; Schwartz TW
Mol Pharmacol; 1997 Feb; 51(2):301-11. PubMed ID: 9203636
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning of a ferret angiotensin II AT(1) receptor reveals the importance of position 163 for Losartan binding.
Gosselin MJ; Leclerc PC; Auger-Messier M; Guillemette G; Escher E; Leduc R
Biochim Biophys Acta; 2000 Jun; 1497(1):94-102. PubMed ID: 10838163
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells.
Chansel D; Bizet T; Vandermeersch S; Pham P; Levy B; Ardaillou R
Am J Physiol; 1994 Mar; 266(3 Pt 2):F384-93. PubMed ID: 8160786
[TBL] [Abstract][Full Text] [Related]
17. A computer modeling postulated mechanism for angiotensin II receptor activation.
Joseph MP; Maigret B; Bonnafous JC; Marie J; Scheraga HA
J Protein Chem; 1995 Jul; 14(5):381-98. PubMed ID: 8590606
[TBL] [Abstract][Full Text] [Related]
18. Site-directed mutagenesis of the gerbil and human angiotensin II AT(1) receptors identifies amino acid residues attributable to the binding affinity for the nonpeptidic antagonist losartan.
Hoe KL; Saavedra JM
Mol Pharmacol; 2002 Jun; 61(6):1404-15. PubMed ID: 12021402
[TBL] [Abstract][Full Text] [Related]
19. AT1 receptor characteristics of angiotensin analogue binding in human synovium.
Walsh DA; Suzuki T; Knock GA; Blake DR; Polak JM; Wharton J
Br J Pharmacol; 1994 Jun; 112(2):435-42. PubMed ID: 8075862
[TBL] [Abstract][Full Text] [Related]
20. Modulation of angiotensin II binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the DuP-753-sensitive angiotensin II receptor of bovine adrenal glomerulosa.
Boulay G; Servant G; Luong TT; Escher E; Guillemette G
Mol Pharmacol; 1992 Apr; 41(4):809-15. PubMed ID: 1569928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
